En español
NIDA

NIDA Notes Staff

Revised September 2018

Editorial Staff

  • Editor, David Anderson, NIDA
  • Managing Editor, Barbara Breen Vann, CSR, Incorporated
  • Science Editor, Susanne Hiller-Sturmhöfel, Ph.D., CSR, Incorporated
  • Associate Editor, Kristin Blank, M.F.A., IQ Solutions
  • Senior Science Writer, Eric Sarlin, M.A., M.Ed., CSR, Incorporated
  • Creative Director, Martín Castillo, IQ Solutions
  • Marketing Associate, Michelle Correll, M.P.H., CIRS, IQ Solutions
  • Research Analyst, Cindy Kwan, M.P.H., IQ Solutions

NIDA Notes Editorial Board Members

  • David Anderson, Chair; Public Health Advisor, Office of Science Policy and Communications
  • Olivier Berton, Ph.D., Health Scientist Administrator, Integrative Neuroscience Branch
  • Kristopher Bough, Ph.D., Health Science Administrator, Division of Basic Neuroscience and Behavioral Research
  • Harold Gordon, Ph.D., Psychologist, Epidemiology Research Branch
  • Peter Hartsock, Ph.D., Scientist Officer, Epidemiology Research Branch
  • Richard A. Jenkins, Ph.D., Health Scientist Administrator, Prevention Research Branch
  • Heather L. Kimmel, Ph.D., Health Scientist Administrator, Epidemiology Research Branch
  • Roger Little, Ph.D., Deputy Director, Division of Neuroscience and Behavior
  • Jacqueline Lloyd, Ph.D., Acting Branch Chief, Prevention Research Branch
  • David J. McCann, Ph.D., Associate Director, Division of Pharmacotherapies and Medical Consequences of Drug Abuse
  • Ivan Montoya, M.D., M.P.H., Deputy Director, Division of Therapeutics and Medical Consequences
  • Vani Pariyadath, Ph.D., Program Officer, Integrative Neuroscience Branch
  • Kenzie Preston, Ph.D., Branch Chief, Clinical Pharmacology and Therapeutics Research Branch
  • John Satterlee, Ph.D., Health Scientist Administrator, Division of Neuroscience and Behavior
  • Rita Valentino, Ph.D., Director, Division of Neuroscience and Behavior
  • Eric Wargo, Ph.D., Science Writer, Office of Science Policy and Communications
  • Cora Lee Wetherington, Ph.D., Program Officer, Behavioral and Cognitive Neuroscience Branch

This page was last updated September 2018

NIDA Notes

Tags

Drug Topics

Drugs of Abuse

Population Groups

Related Topics